Enliven Therapeutics (ELVN) Depreciation & Amortization (CF) (2019 - 2026)
Enliven Therapeutics (ELVN) posted Depreciation & Amortization (CF) of $7,000 for Q2 2026, down 91.4% from $81,000 a year earlier and down 50.0% from the prior quarter.
Powered by 
Analysis
Enliven Therapeutics (ELVN) Depreciation & Amortization (CF) (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Enliven Therapeutics was $166,000, down 44.3% year-over-year; for FY2025, it came in at $300,000, unchanged from FY2024.
- Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 24.6% (FY2020 to FY2025).
- In prior years, Enliven Therapeutics' Depreciation & Amortization (CF) was $300,000 in FY2024 (unchanged), $300,000 in FY2023 (+50.0%), $200,000 in FY2022 (+100.0%) and $100,000 in FY2021 (unchanged).
- The Q2 2026 figure stands as the lowest quarterly Depreciation & Amortization (CF) in data going back to Q4 2019.
- On a year-over-year basis, Depreciation & Amortization (CF) increased in three of the last eight quarters, with an average decline of 23.4%.
- The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q3 2022, with growth of 150.0%; the weakest was Q1 2023, with a decline of 99.8%.
- According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $14,000 (Q1 2026), $83,000 (Q4 2025) and $62,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 534.00 Mn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 1.96 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 194.00 Mn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 599.00 Mn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 1.93 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.11 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 98.00 Mn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 1.62 Bn |
| 10 | Enliven Therapeutics | 3.38 Bn | 3.38 Bn | - | 7,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7,000.00 |
| Mar 31, 2026 | 14,000.00 |
| Dec 31, 2025 | 83,000.00 |
| Sep 30, 2025 | 62,000.00 |
| Jun 30, 2025 | 81,000.00 |
| Mar 31, 2025 | 74,000.00 |
| Dec 31, 2024 | 63,000.00 |
| Sep 30, 2024 | 80,000.00 |
| Jun 30, 2024 | 79,000.00 |
| Mar 31, 2024 | 79,000.00 |
| Dec 31, 2023 | 80,000.00 |
| Sep 30, 2023 | 79,000.00 |
| Jun 30, 2023 | 74,000.00 |
| Mar 31, 2023 | 67,000.00 |
| Dec 31, 2022 | 49,000.00 |
| Sep 30, 2022 | 60,000.00 |
| Jun 30, 2022 | 52,000.00 |
| Mar 31, 2022 | 39.00 Mn |
| Dec 31, 2021 | 26,000.00 |
| Sep 30, 2021 | 24,000.00 |
API Access
Enliven Therapeutics Depreciation & Amortization (CF) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ELVN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "depreciation-and-amortization-cf", "ticker": "ELVN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=ELVN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();